日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

CD30 CAR-T cells in combination with anti-PD-1 camrelizumab in relapsed/refractory CD30(+) lymphomas

CD30 CAR-T细胞联合抗PD-1卡瑞利珠单抗治疗复发/难治性CD30(+)淋巴瘤

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-026-07967-9
Yu, Min; Liu, Longzi; Zhou, Xiaoxi; Zhou, Yulan; Xu, Shan; Kong, Fancong; Qi, Ling; Wu, Jing; Zhang, Tongcun; Li, Fei
T细胞
淋巴瘤
CD30
CD3
T细胞
细胞生物学
PD-1
免疫/内分泌
发表日期：2026
文献求助 收藏

CDKN1A as a potential target for Eltrombopag treatment in ITP and its regulation of the communication between macrophages and transitional B cells in ITP

CDKN1A作为ITP中Eltrombopag治疗的潜在靶点及其对ITP中巨噬细胞和过渡性B细胞之间通讯的调控

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-025-06436-5
Wang, Shixuan; Ju, Mankai; Kong, Fancong; Jiang, Yuhuan; Tu, Yechao; Zou, Jingyun; Zou, Zhiming; Tan, Genmei; Li, Fei
B细胞
巨噬细胞
巨噬细胞
信号转导
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Application of image recognition technology in pathological diagnosis of blood smears

图像识别技术在血涂片病理诊断中的应用

期刊:Clinical and Experimental Medicine
影响因子:3.5
doi:10.1007/s10238-024-01379-z
Cheng, Wangxinjun; Liu, Jingshuang; Wang, Chaofeng; Jiang, Ruiyin; Jiang, Mei; Kong, Fancong
发表日期：2024
文献求助 收藏

Plasma concentrations of venetoclax and Pharmacogenetics correlated with drug efficacy in treatment naive leukemia patients: a retrospective study

维奈托克血浆浓度和药物遗传学与初治白血病患者药物疗效的相关性：一项回顾性研究

期刊:Pharmacogenomics Journal
影响因子:2.9
doi:10.1038/s41397-024-00359-6
Li, Yue; Wan, Qing; Wan, Jiaqi; Xiao, Xiong; Hu, Jinfang; Yang, Xintong; Kong, Fancong; Wang, Jieyu; Song, Baoquan; Li, Zhentao; Li, Fei; Ren, Simei; Peng, Hongwei
白血病
发表日期：2024
文献求助 收藏

Refractory hemophagocytic lymphohistiocytosis secondary to polatuzumab vedotin plus rituximab and bendamustine

难治性噬血细胞性淋巴组织细胞增生症继发于维妥珠单抗联合利妥昔单抗和苯达莫司汀治疗

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-023-05598-4
Lv, Kebing; Kong, Fancong; Yu, Min; Zhou, Yulan; Li, Fei
细胞生物学
发表日期：2024
文献求助 收藏

A trajectory tracking control system for paddle boat in intelligent aquaculture

智能水产养殖中桨船的轨迹跟踪控制系统

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0290246
Guo, Zhenqi; Zhang, Junfeng; Zeng, Fancong; Zuo, Zhijiang; Pan, Libo; Li, Han
发表日期：2023
文献求助 收藏

Regulation of the cecal microbiota community and the fatty liver deposition by the addition of brewers' spent grain to feed of Landes geese

在朗德鹅饲料中添加啤酒糟对盲肠微生物群落和脂肪肝沉积的调节作用

期刊:Frontiers in Microbiology
影响因子:4
doi:10.3389/fmicb.2022.970563.
Ping Xu,Yuxuan Hong,Pinpin Chen,Xu Wang,Shijie Li,Jie Wang,Fancong Meng,Zutao Zhou,Deshi Shi,Zili Li,Shengbo Cao,Yuncai Xiao
脂肪肝
微生物学
发表日期：2022
文献求助 收藏

A novel amino acid site of N protein could affect the PRRSV-2 replication by regulating the viral RNA transcription

蛋白的一个新氨基酸位点可能通过调节病毒 RNA 转录来影响 PRRSV-2 复制

期刊:BMC Veterinary Research
影响因子:2.3
doi:10.1186/s12917-022-03274-9
Hua Deng #, Ning Xin #, Fancong Zeng #, Feng Wen, Heyou Yi, Chunquan Ma, Shujian Huang, Guihong Zhang, Yao Chen
免疫
微生物学
发表日期：2022
文献求助 收藏

CD5+ diffuse large B-cell lymphoma has heterogeneous clinical features and poor prognosis: a single-center retrospective study in China

CD5+弥漫性大B细胞淋巴瘤具有异质性临床特征和不良预后：一项中国单中心回顾性研究

期刊:Journal of International Medical Research
影响因子:1.5
doi:10.1177/03000605221110075
Yin, Ting; Qi, Ling; Zhou, Yulan; Kong, Fancong; Wang, Shixuan; Yu, Min; Li, Fei
B细胞
CD5
淋巴瘤
细胞生物学
免疫/内分泌
发表日期：2022
文献求助 收藏

A retrospective cohort study of polatuzumab vedotin combined with immunochemotherapy in Chinese patients with relapse/refractory diffuse large B cell lymphoma

一项回顾性队列研究，探讨维多珠单抗联合免疫化疗治疗中国复发/难治性弥漫性大B细胞淋巴瘤患者的疗效

期刊:Annals of Translational Medicine
影响因子:
doi:10.21037/atm-22-4593
Liu, Yanyan; Wuxiao, Zhijun; Kong, Fancong; Feng, Jifeng; Wu, Jianqiu; Yao, Zhihua; Zhou, Weilun; Li, Fei
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2022
文献求助 收藏